Parabilis Medicines
Initial Transaction Details
Transaction Date
October 2016
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Equity
Parabilis Medicines (formerly FogPharma) is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer. Through its Helicon discovery platform, Parabilis is engineering precisely tuned, stabilized helical peptide therapeutics that have the potential to unlock a large number of traditionally undruggable targets. This versatile platform enables applications for Helicons across three main areas: functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals.
Website